Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $89.8000 (-2.67%) ($89.2900 - $92.8800) on Mon. Aug. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.46% (three month average) | RSI | 41 | Latest Price | $89.8000(-2.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.6% a day on average for past five trading days. | Weekly Trend | LGND declines -0.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(50%) IWN(50%) IWO(50%) IWC(48%) IBB(47%) | Factors Impacting LGND price | LGND will decline at least -1.73% in a week (0% probabilities). UUP(-18%) VXX(-16%) VIXM(-8%) TBT(-8%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.73% (StdDev 3.46%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $93.63 | 5 Day Moving Average | $92.85(-3.28%) | 10 Day Moving Average | $93.06(-3.5%) | 20 Day Moving Average | $93.63(-4.09%) | To recent high | -6.7% | To recent low | 20.7% | Market Cap | $1.443b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |